Fuller & Thaler Asset Management’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-271,384
| Closed | -$1.47M | – | 478 |
|
|
2018
Q3 | $1.47M | Hold |
271,384
| – | – | 0.02% | 321 |
|
|
2018
Q2 | $963K | Hold |
271,384
| – | – | 0.01% | 332 |
|
|
2018
Q1 | $556K | Sell |
271,384
-20,300
| -7% | -$41.6K | 0.01% | 348 |
|
|
2017
Q4 | $770K | Sell |
291,684
-93,655
| -24% | -$247K | 0.01% | 330 |
|
|
2017
Q3 | $2.02M | Sell |
385,339
-1,900
| -0.5% | -$9.98K | 0.02% | 244 |
|
|
2017
Q2 | $1.38M | Sell |
387,239
-1,500
| -0.4% | -$5.34K | 0.02% | 260 |
|
|
2017
Q1 | $2.01M | Hold |
388,739
| – | – | 0.03% | 213 |
|
|
2016
Q4 | $1.48M | Hold |
388,739
| – | – | 0.02% | 226 |
|
|
2016
Q3 | $3.48M | Sell |
388,739
-11,900
| -3% | -$107K | 0.06% | 162 |
|
|
2016
Q2 | $2.82M | Hold |
400,639
| – | – | 0.05% | 167 |
|
|
2016
Q1 | $3.41M | Sell |
400,639
-127,800
| -24% | -$1.09M | 0.07% | 148 |
|
|
2015
Q4 | $6.94M | Buy |
528,439
+25,000
| +5% | +$328K | 0.15% | 114 |
|
|
2015
Q3 | $1.84M | Buy |
503,439
+400
| +0.1% | +$1.46K | 0.05% | 204 |
|
|
2015
Q2 | $2.9M | Buy |
503,039
+10,500
| +2% | +$60.5K | 0.08% | 174 |
|
|
2015
Q1 | $2.88M | Sell |
492,539
-1,600
| -0.3% | -$9.34K | 0.09% | 182 |
|
|
2014
Q4 | $3.87M | Buy |
494,139
+7,400
| +2% | +$58K | 0.14% | 156 |
|
|
2014
Q3 | $2.39M | Sell |
486,739
-100
| -0% | -$491 | 0.1% | 183 |
|
|
2014
Q2 | $3.01M | Sell |
486,839
-66,861
| -12% | -$413K | 0.13% | 175 |
|
|
2014
Q1 | $2.96M | Sell |
553,700
-65,000
| -11% | -$348K | 0.14% | 178 |
|
|
2013
Q4 | $3.24M | Sell |
618,700
-15,900
| -3% | -$83.2K | 0.18% | 170 |
|
|
2013
Q3 | $3.5M | Sell |
634,600
-9,500
| -1% | -$52.4K | 0.21% | 162 |
|
|
2013
Q2 | $1.63M | Buy |
+644,100
| New | +$1.63M | 0.11% | 216 |
|